calcium phosphate 0.132 MEQ / magnesium carbonate 0.107 MEQ / potassium chloride 0.537 MEQ Oral Tablet
RxNorm concept 1090845, clinical drug (scd).
- RxCUI
- 1090845
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1090845 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
calcium phosphate 0.132 MEQ / magnesium carbonate 0.107 MEQ / K+ Chloride 0.537 MEQ Oral Tablet; calcium phosphate 0.132 MEQ / magnesium carbonate 0.107 MEQ / Pot Chloride 0.537 MEQ Oral Tablet
Related concepts
- potassium chloride 0.537 MEQ (SCDC, consists of)
- calcium phosphate 0.132 MEQ (SCDC, consists of)
- magnesium carbonate 0.107 MEQ (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- calcium phosphate 0.132 MEQ / magnesium carbonate 0.107 MEQ / potassium chloride 0.537 MEQ Oral Tablet [Medi-Lyte] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1090845 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1090845 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1090845. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.